Bausch + Lomb's stock remains a "Hold" despite the latest financial results. Here's what investors need to keep in mind.

Orforglipron is Eli Lilly’s weight-loss pill, and Bank of America expects it to enter the market in the second half of 2026 ...

What Happened? Shares of nutrition products company Bellring Brands (NYSE:BRBR) jumped 2.5% in the afternoon session after ...

U.S. stock futures down, investors to focus on Duluth, B. Riley, Worthington earnings. Navan reports strong Q3 but lowers FY ...